LifeMine Therapeutics Appoints Nobel Laureate William G. Kaelin Jr., M.D., to Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--LifeMine Therapeutics Inc, a biopharmaceutical company reinventing drug discovery by mining fungal biodiversity to develop mechanistically and structurally novel therapeutics, today announced the appointment of William G. Kaelin Jr., M.D., to its board of directors. Dr. Kaelin is the Sidney Farber Professor in the Department of Medicine at the Dana-Farber Cancer Institute and at the Brigham and Women's Hospital at Harvard Medical School, as well as a Howard Hu